14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $31.23 $31.23 Wednesday, 8th May 2024 IMGN stock ended at $31.23. During the day the stock fluctuated 0% from a day low at $31.23 to a day high of $31.23.
90 days $31.22 $31.25
52 weeks $12.43 $31.25

Historical ImmunoGen prices

Date Open High Low Close Volume
May 08, 2024 $31.23 $31.23 $31.23 $31.23 0
May 07, 2024 $31.23 $31.23 $31.23 $31.23 0
May 06, 2024 $31.23 $31.23 $31.23 $31.23 0
May 03, 2024 $31.23 $31.23 $31.23 $31.23 0
May 02, 2024 $31.23 $31.23 $31.23 $31.23 0
May 01, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 30, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 29, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 26, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 25, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 24, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 23, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 22, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 19, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 18, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 17, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 16, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 15, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 12, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 11, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 10, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 09, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 08, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 05, 2024 $31.23 $31.23 $31.23 $31.23 0
Apr 04, 2024 $31.23 $31.23 $31.23 $31.23 0

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use IMGN stock historical prices to predict future price movements?
Trend Analysis: Examine the IMGN stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the IMGN stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT